Craniofacial |
∼100 |
10, 114, 194, 195
|
Epicanthal folds |
Upward slanting palpebral fissures |
Flat nasal bridge |
Small brachycephalic head |
Small ears |
Small mouth |
Other musculoskeletal abnormalities |
∼100 |
10, 196
|
Hypotonia |
Single transverse palmar crease |
Clinodactyly with wide spacing |
Cognitive impairment |
∼100 |
10, 17, 197
|
Reduced brain volume |
Learning and memory defects |
Dementia |
40–50, increases with age |
12, 13, 14, 15, 16, 17, 18, 198, 199
|
Visual |
18–60, increase with age |
10, 18
|
Hearing |
18–80, increase with age |
10, 18
|
Thyroid disease |
1–54, increase with age |
10, 18, 196, 200, 201
|
Cardiac defects |
40–50 |
202, 203, 204
|
ASD (45%) |
VSD (35%) |
Isolated secundum (8%) |
Isolated PDA (7%) |
Isolated Fallot's (4%) |
Other |
Gastrointestinal defects |
12 |
10 |
Benign hematological abnormalities |
∼100 |
11 |
Neonatal thrombocytopenia |
Neonatal polycythemia |
Neonatal neutrophilia, blast cells |
Macrocytosis |
Preleukemia and leukemia |
TAM and silent TAM |
30 |
11, 53
|
Acute myeloid leukemia |
1 |
53 |
Acute lymphoblastic leukemia |
1 |
53 |
Non-hematologic cancers |
50% of risk of individuals without DS |
18, 53, 56, 58, 59
|